US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist

13.050
-0.520-3.83%

Close Dec 27 16:00 ET

339.97MMarket Cap-62.14P/E (TTM)

Eton Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

46.90%10.32M

-24.36%9.07M

50.19%7.97M

48.90%31.64M

-13.94%7.31M

118.33%7.03M

63.05%12M

143.75%5.3M

-2.66%21.25M

39.47%8.5M

Operating revenue

46.90%10.32M

-24.36%9.07M

50.19%7.97M

48.90%31.64M

-13.94%7.31M

118.33%7.03M

63.05%12M

143.75%5.3M

-2.66%21.25M

39.47%8.5M

Cost of revenue

53.22%4.02M

48.94%3.45M

51.12%2.96M

52.62%10.58M

72.26%3.68M

118.57%2.63M

-15.66%2.32M

130.62%1.96M

145.24%6.93M

474.73%2.14M

Gross profit

43.13%6.3M

-41.89%5.63M

49.64%5.01M

47.09%21.06M

-42.92%3.63M

118.19%4.4M

109.89%9.68M

152.15%3.35M

-24.66%14.32M

11.17%6.36M

Operating expense

17.01%5.79M

47.63%8.56M

-1.24%5.81M

-1.44%22.25M

6.13%5.62M

0.77%4.95M

-2.59%5.8M

-8.33%5.88M

10.14%22.58M

20.22%5.3M

Selling and administrative expenses

21.96%5.29M

19.62%5.59M

-3.54%5.16M

1.88%18.93M

5.10%4.58M

4.01%4.34M

-11.19%4.67M

11.45%5.35M

30.26%18.58M

16.85%4.35M

-General and administrative expense

21.96%5.29M

19.62%5.59M

-3.54%5.16M

1.88%18.93M

5.10%4.58M

4.01%4.34M

-11.19%4.67M

11.45%5.35M

30.26%18.58M

16.85%4.35M

Research and development costs

-17.89%505K

164.00%2.97M

21.68%651K

-16.87%3.32M

10.91%1.05M

-17.34%615K

63.04%1.13M

-66.93%535K

-35.91%4M

38.62%944K

Operating profit

192.88%509K

-175.59%-2.94M

68.43%-800K

85.57%-1.19M

-287.66%-1.99M

81.07%-548K

389.78%3.88M

50.19%-2.53M

-452.51%-8.26M

-19.18%1.06M

Net non-operating interest income expense

74.19%-8K

58.06%-52K

91.27%-11K

166.10%503K

622.67%784K

79.33%-31K

43.12%-124K

48.15%-126K

24.35%-761K

45.45%-150K

Non-operating interest expense

-74.19%8K

-58.06%52K

-91.27%11K

----

-79.33%31K

-43.12%124K

-48.15%126K

----

Total other finance cost

----

-166.10%-503K

----

-24.35%761K

----

Other net income (expense)

800K

Special income (charges)

----

--0

----

--0

----

-Gain on sale of property,plant,equipment

----

--0

----

--0

----

Other non- operating income (expenses)

----

--800K

----

Income before tax

186.53%501K

-165.52%-2.99M

69.51%-811K

92.36%-689K

-320.29%-2.01M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

Income tax

-126K

54K

247K

Net income

208.29%627K

-166.70%-3.04M

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

Net income continuous Operations

208.29%627K

-166.70%-3.04M

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

Minority interest income

Net income attributable to the parent company

208.29%627K

-166.70%-3.04M

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

208.29%627K

-166.70%-3.04M

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

Basic earnings per share

200.00%0.02

-166.67%-0.12

70.00%-0.03

88.89%-0.04

-325.00%-0.09

83.33%-0.02

400.00%0.18

52.38%-0.1

-350.00%-0.36

0.00%0.04

Diluted earnings per share

200.00%0.02

-166.67%-0.12

70.00%-0.03

88.89%-0.04

-325.00%-0.09

83.33%-0.02

400.00%0.18

52.38%-0.1

-350.00%-0.36

0.00%0.04

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	46.90%10.32M	-24.36%9.07M	50.19%7.97M	48.90%31.64M	-13.94%7.31M	118.33%7.03M	63.05%12M	143.75%5.3M	-2.66%21.25M	39.47%8.5M
Operating revenue	46.90%10.32M	-24.36%9.07M	50.19%7.97M	48.90%31.64M	-13.94%7.31M	118.33%7.03M	63.05%12M	143.75%5.3M	-2.66%21.25M	39.47%8.5M
Cost of revenue	53.22%4.02M	48.94%3.45M	51.12%2.96M	52.62%10.58M	72.26%3.68M	118.57%2.63M	-15.66%2.32M	130.62%1.96M	145.24%6.93M	474.73%2.14M
Gross profit	43.13%6.3M	-41.89%5.63M	49.64%5.01M	47.09%21.06M	-42.92%3.63M	118.19%4.4M	109.89%9.68M	152.15%3.35M	-24.66%14.32M	11.17%6.36M
Operating expense	17.01%5.79M	47.63%8.56M	-1.24%5.81M	-1.44%22.25M	6.13%5.62M	0.77%4.95M	-2.59%5.8M	-8.33%5.88M	10.14%22.58M	20.22%5.3M
Selling and administrative expenses	21.96%5.29M	19.62%5.59M	-3.54%5.16M	1.88%18.93M	5.10%4.58M	4.01%4.34M	-11.19%4.67M	11.45%5.35M	30.26%18.58M	16.85%4.35M
-General and administrative expense	21.96%5.29M	19.62%5.59M	-3.54%5.16M	1.88%18.93M	5.10%4.58M	4.01%4.34M	-11.19%4.67M	11.45%5.35M	30.26%18.58M	16.85%4.35M
Research and development costs	-17.89%505K	164.00%2.97M	21.68%651K	-16.87%3.32M	10.91%1.05M	-17.34%615K	63.04%1.13M	-66.93%535K	-35.91%4M	38.62%944K
Operating profit	192.88%509K	-175.59%-2.94M	68.43%-800K	85.57%-1.19M	-287.66%-1.99M	81.07%-548K	389.78%3.88M	50.19%-2.53M	-452.51%-8.26M	-19.18%1.06M
Net non-operating interest income expense	74.19%-8K	58.06%-52K	91.27%-11K	166.10%503K	622.67%784K	79.33%-31K	43.12%-124K	48.15%-126K	24.35%-761K	45.45%-150K
Non-operating interest expense	-74.19%8K	-58.06%52K	-91.27%11K	----	----	-79.33%31K	-43.12%124K	-48.15%126K	----	----
Total other finance cost	----	----	----	-166.10%-503K	----	----	----	----	-24.35%761K	----
Other net income (expense)							800K
Special income (charges)	----	----	----	--0	----	----	----	----	--0	----
-Gain on sale of property,plant,equipment	----	----	----	--0	----	----	----	----	--0	----
Other non- operating income (expenses)	----	----	----	----	----	----	--800K	----	----	----
Income before tax	186.53%501K	-165.52%-2.99M	69.51%-811K	92.36%-689K	-320.29%-2.01M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K
Income tax	-126K	54K	0	247K	247K	0	0	0	0	0
Net income	208.29%627K	-166.70%-3.04M	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K
Net income continuous Operations	208.29%627K	-166.70%-3.04M	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K
Minority interest income
Net income attributable to the parent company	208.29%627K	-166.70%-3.04M	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	208.29%627K	-166.70%-3.04M	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K
Basic earnings per share	200.00%0.02	-166.67%-0.12	70.00%-0.03	88.89%-0.04	-325.00%-0.09	83.33%-0.02	400.00%0.18	52.38%-0.1	-350.00%-0.36	0.00%0.04
Diluted earnings per share	200.00%0.02	-166.67%-0.12	70.00%-0.03	88.89%-0.04	-325.00%-0.09	83.33%-0.02	400.00%0.18	52.38%-0.1	-350.00%-0.36	0.00%0.04
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data